scispace - formally typeset
J

Jing Xu

Researcher at Peking Union Medical College

Publications -  93
Citations -  2289

Jing Xu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 74 publications receiving 1592 citations. Previous affiliations of Jing Xu include Shanxi Medical University & Huazhong University of Science and Technology.

Papers
More filters
Journal ArticleDOI

Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage

TL;DR: It is shown that a double cut HDR donor, which is flanked by single guide RNA (sgRNA)-PAM sequences and is released after CRISPR/Cas9 cleavage, increases HDR efficiency by twofold to fivefold relative to circular plasmid donors.
Journal ArticleDOI

CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice

TL;DR: It is demonstrated that CRIPSR-mediated genome editing efficiently excised a 23-kb genomic region on the X-chromosome covering the mutant exon 23 in a mouse model of DMD, and restored dystrophin expression and the dyStrophin-glycoprotein complex at the sarcolemma of skeletal muscles in live mdx mice.
Journal ArticleDOI

SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages

TL;DR: The results indicate that SIRT1 may be a mediator of CR-induced macrophage regulation, and its deacetylase activity contributes to the inhibition of AP-1 transcriptional activity and COX-2 expression leading to amelioration of macrophages function.
Journal ArticleDOI

Spatially resolved metabolomics to discover tumor-associated metabolic alterations.

TL;DR: The spatially resolved metabolomics reveal what occurs in cancer at the molecular level, from metabolites to enzymes, and thus provide insights into the understanding of cancer metabolic reprogramming.
Journal ArticleDOI

Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice

TL;DR: It is demonstrated that SIRT1 overexpression in VSMCs reduces SBP and inhibits AngII-induced vascular remodeling in mice, which contributes, at least in part, to the antihypertensive effect of SIRT 1.